Pfizer, Moderna COVID-19 vaccines reduce infection risk by 91%: US CDC
eMediNexus, 09 June 2021
remove_red_eye 561 Views
#Business And Medicine #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Coronavirus Live Count Map India
remove_red_eye 561 Views
COVID-19 Vaccine Updates
Coronavirus Protocols
#Business And Medicine #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Administration of two doses of the Pfizer-BioNTech and Moderna mRNA-based COVID-19 vaccines can diminish the risk of COVID infection by 91%, suggests a new study by the US Centers for Disease Control and Prevention (CDC).It was reported that even a single dose of the mRNA vaccines can decrease the risk of infection by 81%. The estimates include both symptomatic and asymptomatic infections. Additionally, the study suggested that mRNA vaccination is beneficial for individuals who get COVID-19 even after being fully vaccinated (14 or more days after second dose) or partially vaccinated (14 or more days following first dose to 13 days following second dose)… (ET Healthworld – IANS, June 8, 2021)...
Create Account
Login Now
To Read or comment on this article,
create a free account.
Sign Up
to instantly read 30000+ free Articles & 1000+ Case Studies
Already registered?
